HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patients.

AbstractBACKGROUND:
Von Willebrand factor (VWF) is critical for the in vivo survival of factor VIII (FVIII). Since FVIII half-life correlates with VWF-antigen pre-infusion levels, we hypothesized that VWF levels are useful to predict FVIII half-life.
METHODOLOGY:
Standardized half-life studies and analysis of pre-infusion VWF and VWF-propeptide levels were performed in a cohort of 38 patients with severe haemophilia A (FVIII <1 IU/ml), aged 15-44 years. Nineteen patients had blood-group O. Using multivariate linear regression-analysis (MVLR-analysis), the association of VWF-antigen, VWF-propeptide, age and body-weight with FVIII half-life was evaluated.
PRINCIPAL FINDINGS:
FVIII half-life was shorter in blood-group O-patients compared to non-O-patients (11.5+/-2.6 h versus 14.3+/-3.0 h; p = 0.004). VWF-antigen levels correlated with FVIII half-life considerably better in patients with blood-group non-O than O (Pearson-rank = 0.70 and 0.47, respectively). Separate prediction models evolved from MVLR-analysis for blood-group O and non-O patients, based on VWF-antigen and VWF/propeptide ratio. Predicted half-lives deviated less than 3 h of observed half-life in 34/38 patients (89%) or less than 20% in 31/38 patients (82%).
CONCLUSION:
Our approach may identify patients with shorter FVIII half-lives, and adapt treatment protocols when half-life studies are unavailable. In addition, our data indicate that survival of FVIII is determined by survival of endogenous VWF rather than VWF levels per se.
AuthorsKathelijn Fischer, Ronan Pendu, Carina J van Schooten, Karin van Dijk, Cécile V Denis, H Marijke van den Berg, Peter J Lenting
JournalPloS one (PLoS One) Vol. 4 Issue 8 Pg. e6745 (Aug 25 2009) ISSN: 1932-6203 [Electronic] United States
PMID19707594 (Publication Type: Journal Article)
Chemical References
  • ABO Blood-Group System
  • von Willebrand Factor
  • Factor VIII
Topics
  • ABO Blood-Group System
  • Adolescent
  • Adult
  • Animals
  • Cohort Studies
  • Factor VIII (metabolism)
  • Half-Life
  • Hemophilia A (blood)
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged
  • Young Adult
  • von Willebrand Factor (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: